Adenoviruses Using the Cancer Marker EphA2 as a Receptor In Vitro and In Vivo by Genetic Ligand Insertion into Different Capsid Scaffolds

Adenoviral gene therapy and oncolysis would critically benefit from targeted cell entry by genetically modified capsids. This requires both the ablation of native adenovirus tropism and the identification of ligands that remain functional in virus context. Here, we establish cell type-specific entry...

Descripción completa

Detalles Bibliográficos
Autores principales: Behr, Michael, Kaufmann, Johanna K., Ketzer, Patrick, Engelhardt, Sarah, Mück-Häusl, Martin, Okun, Pamela M., Petersen, Gabriele, Neipel, Frank, Hassel, Jessica C., Ehrhardt, Anja, Enk, Alexander H., Nettelbeck, Dirk M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997477/
https://www.ncbi.nlm.nih.gov/pubmed/24760010
http://dx.doi.org/10.1371/journal.pone.0095723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997477/
https://www.ncbi.nlm.nih.gov/pubmed/24760010
http://dx.doi.org/10.1371/journal.pone.0095723

Ejemplares similares